Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Large group of MEK-inhibitory quinolines discovered at AstraZeneca

Dec. 18, 2000

Potent MMP inhibitor delays osteolytic disease associated with breast cancer metastasis

Dec. 18, 2000

S-1 appears to safely improve survival in metastatic breast cancer patients

Dec. 18, 2000

Arzoxifene has identical effects to tamoxifen in endometrial cancer models

Dec. 18, 2000

EntreMed commences phase I trial of Angiostatin by s.c. injection

Dec. 18, 2000

Cytochroma collaborates with Johns Hopkins on vitamin D-related drug discovery

Dec. 18, 2000

ODAC unanimously recommends approval of Femara as first-line breast cancer treatment

Dec. 15, 2000

New progesterone receptor modulators continue to emerge from AHP/Ligand alliance

Dec. 15, 2000

Genetic Therapy constructs promising new antiangiogenic gene therapy

Dec. 15, 2000

Carborane-based retinoid receptor antagonists presented at recent scientific meeting

Dec. 15, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...